Podiatrists in Casper, WY Accepting Medicare
6 Podiatrists found. Showing 1 - 6
 Dr. Michael Paul Wilkinson, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2233 E 2nd St, Casper, WY 82609 Phone: 307-237-3668 Fax: 307-237-1180 |
John H Nelson, DPM Podiatrist - Foot Surgery Medicare: Not Enrolled in Medicare Practice Location: 1916 E 1st St, Casper, WY 82601 Phone: 307-266-4415 Fax: 307-472-4414 |
Dr. Daniel Taylor Jones, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2233 E 2nd St, Casper, WY 82609 Phone: 925-768-3999 |
Dr. Eric M Dash, DPM Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 1916 E 1st St, Suite 1, Casper, WY 82601 Phone: 307-682-4954 Fax: 307-472-4414 |
 The Foot Clinic Llc Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 1916 E 1st St, Casper, WY 82601 Phone: 307-266-4415 Fax: 307-472-4414 |
Foot Doctor Pc Podiatrist - Foot Surgery Medicare: Medicare Enrolled Practice Location: 2233 E 2nd St, Casper, WY 82609 Phone: 307-237-3668 |
News Archive
Annual follow up after ESD for early gastric cancer recommended
Almost all recurrent lesions in gastric epithelial cancer could be cured by endoscopic submucosal resection with annual follow-up exams, say the authors of a Japanese study.
US children with cystic fibrosis have better lung function compared to UK counterparts
There are significant differences in the lung function of children and young adults in the United States (US) who have cystic fibrosis compared with those in the United Kingdom (UK).
GenMark's eSensor technology selected for Warfarin clinical study
GenMark Diagnostics, Inc., a provider of automated, multiplex molecular diagnostic testing systems, announced today that their eSensor Warfarin Sensitivity Test has been selected for use in a new pivotal Warfarin clinical study the WARFARIN Trial.
Mount Sinai launches CombiRx trial to treat relapsing-remitting Multiple Sclerosis
Mount Sinai School of Medicine is the Clinical Coordinating Center for the first study to assess the effectiveness of combining two FDA approved medications as initial treatment for people with Relapsing Remitting Multiple Sclerosis.
› Verified 8 days ago
Physical Therapists
Occupational Therapists
Speech-Language Pathologists
Optometrists
Chiropractors
Audiologists
Podiatrists